Skip to main content

About your Search

20130101
20130131
Search Results 0 to 11 of about 12 (some duplicates have been removed)
2 diabetes and you're still not getting the control you want call now or visit controlispossible.com. you have a chance to help control your blood sugar for yourself and for those who depend on you most. with your free "chance at control kit", you'll get facts about insulin and how it can lower blood sugar. a meal planning guide that makes sense of food labels, serving sizes and shows how you can still enjoy the foods you love. an award-winning app to access nutritional information and find restaurants. plus a blood sugar diary to help track of your levels and progress. don't put off calling; find out more about adding insulin to your type 2 diabetes treatment for yourself and for them. call now or visit controlispossible.com for your "chance at control kit". it will give you better understanding on insulin and how it can lower blood sugar. call now or visit controlispossible.com. it's a challenge to balance work and family. ♪ that's why i love adt. i can see what's happening at my business from anywhere. [ male announcer ] now manage and help protect your small busines
blood pressure, diabetes, and heat failure are very real. but his biggest concern is that human growth hormone could stimulate the growth of undetected cancer cells such as prostate cancer in men over 50. >> it may well be that it's beneficial for us to have low growth hormones as we age. >> why? >> it may be protecting us from cancer and heart disease. >> if someone has a latent cancer, is there any way to diagnose that before you begin administering human growth hormone? >> unfortunately not. i would be very reluctant to pour fuel onto the fire of a cancer by adding a very powerful growth factor. >> does this bother you? >> of course it bothers me. it bothers me that people are prepared to spend so much money on a molecule which may be unsafe for them. >> hi. dr. mintz. can i help you? >> dr. mintz at cenegenics is undeterred. he says his staff physicians monitor patients carefully and look out for signs of cancer. he also says he's giving human growth hormone to only 7% of his patients, all of whom have natural levels below normal and symptoms that lead him to believe they are growt
, which expects its profits to rise this year. it is also reporting encouraging results on a diabetes drug. they had a pretty good run over the last 12 months, up 29%. joining us live from the jpmorgan health care conference is eli lilly chairman and ceo, dr. john lechleiter. doctor, thank you for coming on the show. >> my pleasure. good morning. >> okay. first i've got to ask, you're a great american company. and you have done so many things right. yet the emphasis for your company has been, don't worry, we talked about a lot of cliffs on cnbc, don't worry about the patent cliff, the cavalry is coming in diabetes and cancer. why not accept the fact that you had a bad patent cliff and tell people not to worry. in 2014, 2015, you'll be in good shape. >> i think that message is starting to come through. first of all, we've been very successful in driving growth in those areas that are sort of countercyclical through this period. our health business, japan would be another example, and china, among our emerging markets. we're also advancing our pipeline. we have 13 molecules in late stage dev
has an advantage when it comes to type ii diabetes. they are further along and in the best position of any farm sewell suit call company to release a serious drug application which is a type two diabetes inhibitor. see a very bright future ahead for j&j. like them both but like j&j better. >> ennis, what do you think? >> i agree with steve. health care as a whole is one of the best stocks to be in but i disagree with j&j over pfizer and if you look at the charts you'll see what i mean. j&j has had a nice uptrend and it has had trouble breaking out above the october high so the october high was around 72, 75ish. it hasn't been able to get up there convincing which whereas if we look at pfizer in contrast you'll see that pfizer has been able to convincingly break out about the october highs showing more strength from the buyers and that's why i like it technically. >> i do think that's an important point. also, let's remember. even though pfizer has done better and most phrma has done better. j&j did print a three-year high so a post-crisis high so it's doing very well itself. the rea
in lifestyle diseases such as heart disease, cancer, diabetes. so there is a trend towards healthier eating. >> all preventible, by the way. >> that's right. there's also a trend, of course, to more junk food. so we have different trends in this society. of course, my business focuses on the healthier trends. that's what wae're trying to do help america eat healthier and live longer. >> you know so much about this. how do you eat? are you a vegan? >> i am, yes. ten years now. no oil vegan. try to avoid eating processed foods like sugar and white flour. it's worked very well for me. i very seldom get sick, feel great. i feel better today at 59 than when i was 39. >> isn't that wonderful? >> it is. >> some people question whether or not organic is worth it. is it worth the extra money? >> i think that it is. it's definitely, i think, better for the environment. it lowers the risk of pesticides in the ground water, pesticides in our own bodies. i think that's a good thing. >> john, it's great to have you on the program. >> great to be here, maria. >> john mackey joining us. up next, why women
with diabetes, and a drug for cholesterol. it has a drug for ulcerative colitis that just got fda approval this week, and it only trades at a slight premium to growth rate. i'm willing to give the stock my blissing, even though it's up very quickly. only for speculation. it can still run ahead of the colitis drug launch in march. this product looks exciting. i liked the stock seven years ago. like it now tweets. david spitsberg cpa. he asks any reason why the only major home builder stock was down? it was up a huge amount. it's been a monster performer. i prefer almost every other home builder to it. pulte home won the stock super bowl. the second tweet from andy. please comment on that. nordic american tanker and what to do after the dividend slash. i don't like nordic american tanker. liked it for a while and the tanker business got really bad. we walked away from it, and i think it's probably with the dividend slash, seems like it's a bottom, i think the worldwide economy doing better. but we said that dividend would have to be slashed one day. what a terrible business. i think the busi
not have to pay out of pocket for all these preventive care procedures. diabetes testing, mammograms, colonoscopies. they are going to avail themselves of these medical procedures. that is going to save money. >> real quick. bill joyce. we've got to go. >> we're in agreement that we need to cut medicare costs, and i can tell you the way they are planning to do it right now, they just -- the 27% across the board reimbursement. i'll tell you what's going to happen. that really threatens medicare because a lot of private physicians and private hospitals are not going to take medicare patients at all and that's a much greater threat, and so i think to get this solvent, i agree with max. we need to get costs under control. that's a big change, and there's very little in the bill to do that. mostly it just involves cutting reimbursement. we need to do that. >> we've got to run, you guys. >> we do not support cutting reimbursements to providers to the point where it will impact adversely access to good health care. we oppose that. >> nobody wants to cut anything. we get that, but we're also
. >> any excuse to say bristol-myers. >> better than expected quarter, before the drug, the diabetes drugs are working and i got to tell you you melanoma drug for real this thing much hire. >> a couple names we don't talk about a lot. gall. >> people want airline stocks, how about a brazilian airline play, goldman recommends, 7 to 14. brazil well. >> buckeye? >> the partnerships, little hype per bolly, every time they have done an equity deal, the right thing to do call your broker. >> jpm ups conning a graham. >> cheapest in show, still gary rod kin, amazing, equity higher. >> how about tonight? >> of a net, find out how the actual chip business is doing. we should stop talking about coach in china but tim kin. >> you are killing it this week. >> very exciting time. >>> it is. >> thank you. >> 6 and 11 tonight. >>> two takes on apple's earnings around the selloff, where the stock goes from here, a company shareholder around an analyst each weigh in on the iphonemaker, plus brian moynihan of bank of america live from davos. do not go away. overmany discounts to thine customers! [old englis
and progress. don't put off calling; find out more about adding insulin to your type 2 diabetes treatment for yourself and for them. call now or visit controlispossible.com for your "chance at control kit". it will give you better understanding on insulin and how it can lower blood sugar. call now or visit controlispossible.com. executor of efficiency. you can spot an amateur from a mile away... while going shoeless and metal-free in seconds. and you...rent from national. because only national lets you choose any car in the aisle...and go. you can even take a full-size or above, and still pay the mid-size price. now this...will work. [ male announcer ] just like you, business pro. just like you. go national. go like a pro. >>> it may be super bowl week, but this is not the 40-yard dash, it's the "mad dash." jim, what's going on here? >> you have to get on the conference call to see why a stock is down so much. there's this gut punch. they give their talk and everybody says, okay, and the first question is, like, and then all the management does is, oh, um, and it says in the transcript it
Search Results 0 to 11 of about 12 (some duplicates have been removed)